Glimicord MV 1mg/500mg/0.2mg Tablet
Marketer
Cordial Lifesciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimicord MV 1mg/500mg/0.2mg Tablet
Diabetic patients using the combination medication, Glimicord MV (1mg/500mg/0.2mg), should be aware that it's an anti-diabetic agent managing type 2 diabetes in adults by regulating blood glucose. Administer this tablet with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as recommended by your healthcare provider. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and be prepared with a rapid-acting glucose source (e.g., sugary foods, juice). Alcohol increases hypoglycemia risk and should be avoided. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medicine is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended under your doctor's supervision.
Uses of Glimicord MV 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glimicord MV 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimicord MV 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
Common Side effects of Glimicord MV 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimicord MV 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimicord MV 1mg/500mg/0.2mg Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.
How Glimicord MV 1mg/500mg/0.2mg Tablet works:
Each Glimicord MV 1mg/500mg/0.2mg tablet combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimicord MV 1mg/500mg/0.2mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Use of Glimicord MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimicord MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.
KidneyUNSAFE
The use of Glimicord MV 1mg/500mg/0.2mg tablets carries a high risk for individuals with kidney impairment and should be diligently avoided. Medical advice from a physician is crucial. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimicord MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glimicord MV 1mg/500mg/0.2mg Tablet :
Should you forget a Glimicord MV 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimicord MV 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently